<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, 13 fatal and 13 survivor EVD-patients were analyzed to address the humoral immune response (anti-EBOV IgM and IgG), using 2 to 7 sequential plasma samples, collected 1 to 3 days apart in a timeframe ranging from 2 and 16 DSO, accounting for a total of 137 plasma samples. The study protocol was approved by the Ethical Committee of Sierra Leone.</p>
